SLC5A2 and hydrops fetalis: Particular attention should be directed towards the findings of the EMPA-REG OUTCOME trial sub-analysis [66], which indicate that the combination of SGLT-2 inhibitors and aldosterone antagonists may worsen HF, potentially due to dehydration and reduced cardiac output [65].